Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Dental Technologies to receive $7.5 million cash for royalty rights.


SACRAMENTO Sacramento, city, United States
Sacramento (săkrəmĕn`tō), city (1990 pop. 369,365), state capital and seat of Sacramento co., central Calif.
, Calif.--(BUSINESS WIRE)--May 20, 1996--Bio-Dental Technologies Corp. (NASDAQ/NM:BDTC BDTC Base de Donnees Toponymiques du Canada (French: Database of Canada Toponymic) ) Monday announced it has signed a letter of intent which will provide the company with a lump sum Lump sum

A large one-time payment of money.
 payment of $7.5 million in cash in lieu Cash In Lieu (CIL)

In a typical exchange offer, "old" shares of the target company are exchanged for "new shares".
 of future royalty payments, which were due to the company from Denticator International Inc. through March 1999.

Denticator, a former subsidiary of Bio-Dental, was sold in 1991, and since that time, Bio-Dental has been receiving royalties from Denticator. The company estimates that the $7.5 million payment approximates the net-present-value of Bio-Dental's projected future royalties, including a scheduled lump-sum payment that would have been due in April 1999.

The letter of intent is part of a transaction in which Denticator International Inc. will be acquired by Young Innovations Inc., located in Earth City, Mo. The transaction is subject to due diligence Research; analysis; your homework. This term has caught on in all industries, because it sounds so "wired." Who would want to do analysis or research when they can do due diligence. See wired.  and other contingencies Contingencies (ISSN 1048-9851) is the bimonthly magazine of the American Academy of Actuaries, providing a large and diverse readership with general interest and technical articles on a wide range of issues related to the actuarial profession.  and is scheduled to close within the next 60 days.

Curtis M. Rocca III, president and chief executive officer of Bio-Dental, said, "The sale of these royalty payments will strengthen the company's balance sheet, eliminate all of our outstanding bank debt and notes payable, and provide us with the highest cash balance that we have ever had."

Bio-Dental Technologies Corp. manufactures, markets, and distributes dental supplies and proprietary, high-technology dental products to the $2 billion professional dental supply market in all 50 states and Canada.

CONTACT: Bio-Dental Technologies Inc., Sacramento

Curtis M. Rocca III, 916/638-8147

or

Silverman Heller Associates

Eugene G. Heller, 310/208-2550
COPYRIGHT 1996 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 20, 1996
Words:248
Previous Article:MacNeal-Schwendler approved for New York Stock Exchange listing.
Next Article:Japanese Scientist Uses High Definition Technology to Develop Visual Communications Markets.
Topics:



Related Articles
Bio-Dental Technologies announces third quarter results.
Bio-Dental Technologies Corp. selected as preferred vendor for leading provider of managed-care dental insurance.
Bio-Dental Technologies Corp. expands managed-care provider program.
Bio-Dental Technologies completes sale of royalties; receives $7.5 million cash payment.
Bio-Dental Technologies reports fiscal 1997 first-quarter results, return to profitability.
Bio-Dental Technologies Corp. signs three-year agreement with The Guardian.
Bio-Dental Technologies Corp. signs three-year agreement with California Dental Health Plan.
BUSINESS NOTES\Developments.
Takara Bio Licenses FLT3 Gene Mutation Detection Method to InVivoScribe Technologies.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles